Reported By:
| Edited By: |Source: Reuters |Updated: Mar 17, 2018, 04:32 AM IST
Shares of Parabolic Drugs debuted on the BSE at Rs76.8 on Thursday, up 2.4% against its issue price of Rs75.
The drugmaker has raised Rs2 billion through its 26.6- million-share initial public offer (IPO) that closed on June 17.
Avendus Capital and ICICI Securities were the lead managers to the issue while SPA Merchant Bankers was the co-lead manager.
At 9.02am, shares were trading at Rs74.4 in a weak Mumbai market.
